secwatch / observer
8-K filed June 14, 2023, 7:59 PM ET ticker PRAX CIK 0001689548
other material confidence high sentiment neutral materiality 0.15

Stockholders elect three directors, ratify auditor, approve executive compensation at 2023 annual meeting

Praxis Precision Medicines, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Praxis Precision Medicines, Inc. shareholders approved Election of Class III Directors at the 2023-06-12 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-12
Exact text from the filing
Proposal 1 – Election of Class III Directors The Company’s stockholders elected Gregory Norden, Marcio Souza and William Young to serve as Class III members of the Board of Directors of the Company (the “Board”) until the Company’s 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal, with the votes cast as follows: Class III Director Nominees Votes For Votes Withheld Broker Non-Vote Gregory Norden 35,093,179 7,366,080 5,199,545 Marcio Souza 35,151,003 7,308,256 5,199,545 William Young 18,353,865 24,105,394 5,199,545
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Praxis Precision Medicines, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-06-12 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-06-12
Exact text from the filing
Proposal 3 – Advisory Vote on Executive Compensation The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 29,790,931 7,738,170 1,033,594 5,199,545
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Praxis Precision Medicines, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm at the 2023-06-12 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-12
Exact text from the filing
Proposal 2 – Ratification of Appointment of Ernst & Young LLP as the Company ’ s Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 47,578,569 18,327 61,908 0
View on SEC.gov

Browse all shareholder votes →

Praxis Precision Medicines, Inc. filing history →

Source: SEC EDGAR
accession 0001689548-23-000105
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.